CMCaiyun Ma

Caiyun Ma

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Caiyun Ma has a total of 51 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Genetic Identification of Potential Drug Targets for Dental Caries: A Mendelian Randomization Study

    by Junlei Bi, Anqi Liu, Na Zhang, Yuxin Chen, Changqing Liu, Yongna Zhu, Hebao Wen, Caiyun Ma

    Background and Aims: Dental caries (DC), a chronic and multifactorial disease, affects billions of people globally, posing a significant public health challenge. Despite its prevalence, the molecular mechanisms underlying DC and effective pharmacological targets remain elusive. This study leverages Mendelian randomization (MR) and large‐scale genomic data to identify potential drug targets for DC. Methods: We utilized eQTL and genome‐wide association studies (GWAS) data to identify genes whose expression is causally linked to DC risk. The eQTL data were extracted from the eQTLGen consortium, and the GWAS data were obtained from the IEU OpenGWAS database. We performed MR analysis using the R package TwoSampleMR and validated the results in the FinnGen cohort. We integrated phenome‐wide association studies (PheWAS), gene ontology (GO), and protein–protein interaction (PPI) network construction to explore the potential roles of the identified genes. Molecular docking studies were conducted to identify potential therapeutic agents targeting TUBB. Results: We identified 32 genes whose expression is causally linked to DC risk. Further validation in the FinnGen cohort narrowed these down to nine key genes: EIF4G3, PREX1, ZFYVE19, TUBB, CBLL1‐AS1, EDAR, ADRA2A, BBS10, and TCTN1. These genes were analyzed to explore their roles in dental caries. Molecular docking studies identified paclitaxel and mebendazole as potential therapeutic agents targeting TUBB, with binding energies as low as −9.2 kcal/mol, indicating strong binding affinity. Conclusion: We identified nine novel candidate drug targets for DC through a comprehensive MR approach combined with multi‐omics analyses. These findings highlight the potential of these genes as therapeutic targets and provide valuable insights into the genetic basis of dental caries. The findings provide insights into the genetic basis of DC and highlight targets for future therapeutic development, though experimental validation is required.

  • Open Access

    Characteristics and Multilineage Differentiation of a Novel Type of Pulmonary Mesenchymal Stem Cells Derived from Goose Embryos

    by Caiyun Ma, Hanan Song, Baoku Sui, Yang Zhang, Yue Wu, Yunan Wang, Weijun Guan, Changqing Liu, Hebao Wen

    Pulmonary mesenchymal stem cells (PMSCs) are considered important in therapeutic and regenerative responses to lung injury. Despite extensive studies on the human, porcine, sheep, mouse and rat, it was found that PMSCs, which can been performed on goose, have not been well explored. Elucidation of cell differentiation, proliferation, which have not yet been well described, may promote the development of injured lung therapy. In our study, we firstly disclosed biological characteristics of spindle-shaped PMSCs from pulmonary tissues of goose embryos. Growth kinetics and counting kit-8 (CCK8) assay were employed for proliferative activity evaluation. When appropriately induced, PMSCs could differentiate into osteoblasts, adipocytes, chondrocytes, type II alveolar epithelial cells (ATII), which demonstrated that PMSCs have cross-embryonic layer differentiation potential. Besides, undifferentiated PMSCs consistently expressed MSCs associated phenotypes, such as CD166, CD90, CD44, CD29, CD71 and CD105, as identified by immunohistochemistry and RT-PCR. Karyotype analysis demonstrated that PMSCs possessed stable diploid karyotype. Collectively, we successfully established applicable methods for isolation, culture, identification and characterization of goose PMSCs which suggested a potential therapeutic use in regenerative therapy.

  • Open Access

    In Vitro Culture and Multipotency Evaluation of Broiler Umbilical Cord Mesenchymal Stem Cells

    by Caiyun Ma, Gaofeng Liu, Chunjing Wang, Yu Guo, Weijun Guan, Changqing Liu, Hebao Wen

  • Three-dimensional Au/carbon nanotube-graphene foam hybrid nanostructure for dendrite free sodium metal anode with long cycle stability

    by Zhenxin Huang, Zixuan Wang, Bofang Tian, Tingting Xu, Caiyun Ma, Zhuangfei Zhang, Jinhao Zang, Dezhi Kong, Xinjian Li, Ye Wang


  • Open Access

    Isolation, culture and biological characteristics of multipotent porcine tendon-derived stem cells

    by Jinjuan Yang, Qianjun Zhao, Kunfu Wang, Caiyun Ma, Hao Liu, Yingjie Liu, Weijun Guan

    Tendon-derived stem cells (TDSCs), a postulated multi-potential stem cell population, play significant role in the postnatal replenishment of tendon injuries. However, the majority of experimental materials were obtained from horse, rat, human and rabbit, but rarely from pig. In this research, 1‑day‑old pig was chosen as experimental sample source to isolate and culture TDSCs in vitro. Specific markers of TDSCs were then characterized by immunofluorescence and reverse transcription polymerase chain reaction (RT‑PCR) assays. The results showed that TDSCs could be expanded for 11 passages in vitro. The expression of specific markers, such as collagen Ⅰ, collagen Ⅲ, α‑smooth muscle actin (α‑SMA), CD105 and CD90 were observed by immunofluorescence and RT‑PCR. TDSCs were induced to differentiate into adipocytes, osteoblasts and chondrocytes, respectively. These results suggest that TDSCs isolated from porcine tendon exhibit the characteristics of multipotent stem cells. TDSCs, therefore, may be potential candidates for cellular transplantation therapy and tissue engineering in tendon injuries.


  • Open Access

    Liver epithelioid progenitor cells derived from fetal Luxi bovine alleviate liver fibrosis

    by Kunfu Wang, Hao Liu, Jinjuan Yang, Caiyun Ma, Zebiao Zhang, Dong Zheng, Weijun Guan

    Liver epithelioid progenitor cells (LEPCs) have important roles in liver therapy because of their hepatic differentiation potency in vitro and in vivo. Despite many researches on humans, mice, and rats, equivalent progenitor cells derived from bovine are relatively rare. The purpose of our current study is to characterize bovine LEPCs, and research on the cure potency of this heteroplastic progenitor cells on mice liver fibrosis. We have used collagenase IV digesting and differential adhesion method to isolate slabstone shape, EpCAM, LGR5, NCAM1 and SOX9 positive progenitor cells from fetal Luxi bovine liver. When cultured in hepatic differentiation media containing 20 ng/ml Oncostatin M, LEPCs can differentiate into hepatocytes in vitro. After 4 weeks of intravenous tail vein injection into CCl4-injured mouse liver, LEPCs engrafted into liver parenchyma, differentiated into ALB positive hepatocytes, and could alleviate liver fibrosis through down regulating fibrosis genes-Tgfb1 and α-SMA as well as decreasing expression of collagen gene Col1a1, Col3a1, and Col4a1, and regain liver function by recovering ALT and AST. Our findings provided a useful tool for studying liver development in vitro, new cell resource for heterograft on mouse liver diseases, and a new platform for researches on immune rejection of heterogeneous cell transplantation.


  • Open Access

    Methylenetetrahydrofolate reductase gene polymorphisms and cerebral palsy in Chinese infants

    by Xiuyong Cheng, Tongchuan Li, Honglian Wang, Dengna Zhu, Caiyun Ma, Bingxiang Ma, Yinghong Wang, Junyu Zhang, Luo Guo, Lei Wang, et al.

    Genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR) have been suggested as being associated with cerebral palsy (CP) but the evidence is uncertain. The purpose of this study was to investigate whether MTHFR gene polymorphisms contribute to the development of CP in Chinese infants. For this study, 169 health controls and 159 infants with CP including 43 cases also suffering from mental retardation (MR) were recruited. Genomic DNA was prepared from venous blood and all five single nucleotide polymorphisms in MTHFR (rs4846049, rs1476413, rs1801131, rs1801133 and rs9651118) were genotyped using TaqMan technology. There were no significant differences in allele or genotype frequencies between the CP patients and controls at any of the five genetic polymorphisms. Subgroup analysis found statistically significant difference in allele and genotype frequencies between cases with both CP and MR (CP + MR) compared with both CP-only cases and controls at rs4846049, rs1476413 and rs1801131. The frequencies of the T alleles of rs4846049, rs1476413 and the G allele of rs1801131 were greater in the CP + MR patients than in the CP-only patients and controls. This study provides the first evidence pointing to a MTHFR gene polymorphism as a potential risk factor for CP combined with MR.